Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on May 22, 2025
Hypofibrinogenemia Market Set to Grow as New Treatments Emerge During the Forecast Period (2025–2034) | DelveInsight
GlobeNewswire
·
May 22, 2025
New York, USA, May 22, 2025 (GLOBE NEWSWIRE) -- Hypofibrinogenemia Market Set to Grow as New Treatments Emerge During the Forecast Period (2025–2034) | DelveInsight DelveInsight projects a promising growth trajectory for the hypofibrinogenemia market …
Press release: Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders
GlobeNewswire
·
May 22, 2025
Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders Ghent, Belgium, 22 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant …
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
GlobeNewswire
·
May 22, 2025
LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced that it has received a ruling to expedite a …
Nisa Foundation’s Brand New Transition House Offers Greater Support and Culturally-Responsive Care for Women and Children Fleeing Violence
GlobeNewswire
·
May 22, 2025
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- In partnership with BC Housing, Nisa Foundation is proud to announce the expansion of Nisa Homes Vancouver, with a brand new location now operating as a 24/7 transition house with double the …
Bio Usawa and Pacific Environmental Technologies Announce Landmark Partnership to Develop and Deploy Modular cGMP Biomanufacturing Units for Africa
GlobeNewswire
·
May 22, 2025
SAN FRANCISCO and KIGALI, Rwanda, May 22, 2025 (GLOBE NEWSWIRE) -- Bio Usawa, Inc., a biopharmaceutical company based in San Francisco, Kigali, and Nairobi, committed to expanding access to life-saving biologics in Africa and underserved regions, today …
Legend Senior Living’s Workplace Culture Earns Seventh Great Place to Work® Certification
GlobeNewswire
·
May 22, 2025
WICHITA, Kan., May 22, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living® has earned its seventh consecutive Great Place to Work® certification, a distinction based on results from an annual, anonymous employee survey conducted by the independent research firm …
Total Ancillary Joins Forces with WoundGenex
GlobeNewswire
·
May 22, 2025
DALLAS, May 22, 2025 (GLOBE NEWSWIRE) -- Providers now will have access to additional support services, thanks to an alliance between leading wound care solutions provider Total Ancillary and WoundGenex, a trusted name in wound care associated …
PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene
GlobeNewswire
·
May 22, 2025
MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized leader in blood typing genomics, as …
Dandy Launches Real-Time Video Collaboration for Dentists and Lab Techs
GlobeNewswire
·
May 22, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Dandy, the fully digital dental lab, today launched a new suite of real-time visual collaboration features for its pioneering Chairside and case management software for dental practices. Dentists and lab techs can …
Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
GlobeNewswire
·
May 22, 2025
BOSTON and LONDON, May 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that Abizer Gaslightwala, President and CEO of Akari, …
BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade
GlobeNewswire
·
May 22, 2025
XI’AN, China, May 22, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive sales cooperation …
Biodexa Announces Award of Additional $3.0M Grant from CPRIT to Support Registrational eRapa Phase 3 Program in FAP Brings Total CPRIT Grant Funding for eRapa Phase 3 Program to $20.0M
GlobeNewswire
·
May 22, 2025
May 22, 2025 Biodexa Announces Award of Additional $3.0M Grant from CPRIT to Support Registrational eRapa Phase 3 Program in FAP Brings Total CPRIT Grant Funding for eRapa Phase 3 Program to $20.0M Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ( …
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
GlobeNewswire
·
May 22, 2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound …
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
GlobeNewswire
·
May 22, 2025
INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually With over 450 active accounts across 24 countries, INBS …
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
GlobeNewswire
·
May 22, 2025
Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointestinal pain and a 49.8% reduction in bloating over an 8-week period First-of-Its-Kind inFoods® IBS Feedback Platform: New real-time …
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia
GlobeNewswire
·
May 22, 2025
NEWPORT BEACH, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced the completion of a Phase I strategic research …
Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025
GlobeNewswire
·
May 22, 2025
Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime cardiogenic shock Phase 3 program WARRINGTON, Pa., May …
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
GlobeNewswire
·
May 22, 2025
PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data to aggressively pursue novel drug discovery, biomarker …
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
GlobeNewswire
·
May 22, 2025
TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the removal of all conditions precedent, related to its …
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
GlobeNewswire
·
May 22, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes …